Immune Regulation News Volume 14.05 | Feb 11 2022

    0
    76







    2022-02-11 | IRN 14.05


    Immune Regulation News by STEMCELL Technologies
    Vol. 14.05 – 11 February, 2022
    TOP STORY

    Marginal Zone B Cells Acquire Dendritic Cell Functions by Trogocytosis

    Scientists determined that complement component 3 bound to peptide-loaded major histocompatibility complex class II molecules exposed on the surface of mouse and human conventional dendritic cells, forming a covalent bond with the carbohydrate moiety of the MHC II α chain.
    [Science]

    Abstract
    Quantify Cytokines with Confidence with High-Performance ELISA Kits
    PUBLICATIONSRanked by the impact factor of the journal

    Loss of TSC1/TSC2 Sensitizes Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

    Researchers found that TSC1/TSC2 loss defined a distinct subtype of non-small cell lung cancercharacterized as inflamed tumor microenvironment and superior sensitivity to immune checkpoint blockade.
    [Science Advances]

    Full Article

    DExD/H-box Helicase 9 Intrinsically Controls CD8+ T Cell–Mediated Antiviral Response through Noncanonical Mechanisms

    Investigators found that T cell–specific deletion of nuclear helicase Dhx9 led to impaired CD8+ T cell survival, effector differentiation, and viral clearance.
    [Science Advances]

    Full Article

    Combining p53 mRNA Nanotherapy with Immune Checkpoint Blockade Reprograms the Immune Microenvironment for Effective Cancer Therapy

    The authors developed and optimized a CXCR4-targeted mRNA nanoparticle platform to effectively induce p53 expression in hepatocellular carcinoma models.
    [Nature Communications]

    Full ArticlePress Release

    Glutaredoxin 1 Controls Monocyte Reprogramming during Nutrient Stress and Protects Mice against Obesity and Atherosclerosis in a Sex-Specific Manner

    Researchers reported that in chow-fed, reproductively senescent female mice but not in age-matched male mice, deficiency in the thiol transferase glutaredoxin 1 promoted dysregulated macrophage phenotypes as well as rapid weight gain and atherogenesis.
    [Nature Communications]

    Full Article

    Post-Transplant Malignancies Show Reduced T Cell Abundance and Tertiary Lymphoid Structures as Correlates of Impaired Cancer Immunosurveillance

    Digital image analysis of whole section slides was used to assess abundance and spatial distribution of T cells and tertiary lymphoid structures in the tumor immune microenvironment of 117 tumor samples.
    [Clinical Cancer Research]

    Abstract

    Single-Cell Transcriptomics Uncovers an Instructive T Cell Receptor Role in Adult γδ T Cell Lineage Commitment

    Single-cell transcriptomics of LAT-deficient double-negative third stage γδint cells demonstrated no sign of commitment to the γδ T-cell lineage, apart from γδ T cell receptor expression.
    [EMBO Journal]

    Full ArticleGraphical Abstract

    Natural Disaster and Immunological Aging in a Nonhuman Primate

    Scientists examined the impact of Hurricane Maria and its aftermath on immune cell gene expression in large, age-matched, cross-sectional samples from free-ranging rhesus macaques living on an isolated island.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Activation and Expansion of T-Follicular Helper Cells in Chronic Lymphocytic Leukemia Nurselike Cell Co-Cultures

    In co-cultures from 28 different chronic lymphocytic leukemia patients, the authors detected an expansion of T-follicular helper cells based on PD-1, BCL6, and ICOS expression, with increased IL-21 and downmodulated CD40L surface expression.
    [Leukemia]

    Abstract

    NAFLD Indirectly Impairs Antigen Specific CD8+ T Cell Immunity against Liver Cancer in Mice

    Scientists generated a doxycycline inducible MHC-I and II antigen expressing hepatocellular carcinoma cell line which allowed them to investigate tumor antigen specific T cell response in two non-alcoholic fatty liver disease (NAFLD) mouse models.
    [iScience]

    AbstractGraphical Abstract

    In Situ Vaccination Using Unique TLR9 Ligand K3-SPG Induces Long-Lasting Systemic Immune Response and Synergizes with Systemic and Local Immunotherapy

    K3-SPG, a second-generation nanoparticulate Toll-like receptor 9 (TLR9) ligand consisting of K-type CpG oligodeoxynucleotide (ODN) wrapped with schizophyllan, integrated the best of conventional CpG ODNs, making it an ideal cancer immunotherapy adjuvant.
    [Scientific Reports]

    Full Article
    Cell Preparation For Crossmatch Assays
    REVIEWS

    Activation Pathways That Drive CD4+ T Cells to Break Tolerance in Autoimmune Diseases

    Investigators review our current understanding of how each of the three signals of CD4+ T cell activation cell plays a role in three different autoimmune diseases and highlight the genetic polymorphisms that predispose individuals to autoimmunity.
    [Immunological Reviews]

    Abstract

    Regulation of Immune Cell Function by Nicotinamide Nucleotide Transhydrogenase

    The authors provides] an overview of nucleotide transhydrogenase (NNT) and focus on the current knowledge of NNT in the immune cells.
    [American Journal of Physiology-Cell Physiology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Intrommune Reports Positive Update from Ongoing Phase I Study in Peanut Allergy

    Intrommune Therapeutics, Inc. announced an initial update from its ongoing Phase I OMEGA Trial of INT301 in patients with peanut allergy.
    [Intrommune Therapeutics, Inc.]

    Press Release

    Husker Researcher Takes Another Step toward Virtual Immune System

    The renewal of a National Institutes of Health grant will enable a University of Nebraska–Lincoln researcher to continue developing a tool that illuminates the complex, multi-scale interplay of the immune system’s many components.
    [Nebraska Today]

    Press Release
    FEATURED EVENT

    Cell Therapy Analytics Symposium

    2 March, 2022
    Online

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scientist – Cellular Immunology/T Cell Therapy

    TU Dresden – Dresden, Germany

    Postdoctoral Research Scientist – Immune Regulation

    Columbia University – New York, New York, United States

    Research Scientist – T Cell Stimulation

    Babraham Institute – Babraham, England, United Kingdom

    Postdoctoral Fellow – Cell Death in the Innate Immune System

    Ragon Institute – Boston, Massachusetts, United States

    Postdoctoral Positions – Atherosclerosis

    Columbia University – New York, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Immune Regulation News Twitter